Most patients with brain tumors receive one of two types of radiation: external beam radiation, in which the tumor is treated over the course of several weeks, or radiosurgery, in which patients receive a high dose of radiation ...
May 6, 2024
0
0
Cancer is a leading cause of death globally. One of the primary reasons why cancer is such a deadly disease is the ability of cancer cells to become drug-resistant.
May 15, 2024
0
0
A study from the laboratory of Shi-Yuan Cheng, Ph.D., professor in the Ken and Ruth Davee Department of Neurology's Division of Neuro-oncology, has identified novel mechanisms underlying RNA splicing events within glioma ...
8 hours ago
0
20
Ultrasound imaging offers a valuable and noninvasive way to find and monitor cancerous tumors. However, much of the most crucial information about a cancer, such as specific cell types and mutations, cannot be learned from ...
May 13, 2024
0
0
Lung cancer remains a leading global health concern, responsible for the highest number of cancer-related deaths worldwide. Central to its development is the tumor microenvironment, which involves a complex interplay with ...
May 15, 2024
0
1
Immunotherapies have revolutionized cancer treatment by harnessing the body's own immune system to attack cancer cells and halt tumor growth. However, these therapies often need to be tailored to each individual patient, ...
May 16, 2024
0
16
Colorectal cancer differs from patient to patient. That is why scientists are looking for characteristic tumor markers that allow them to make predictions about the likely response to certain therapies and the individual ...
May 16, 2024
0
1
In a development in cancer research, scientists are exploring new therapeutic strategies that move beyond traditional cytotoxic treatments, which have historically targeted uncontrolled cell proliferation.
Apr 30, 2024
0
0
As the numbers of pediatric brain cancer survivors continue improving, the numbers of individuals developing life-long neurocognitive impairments are consequently expected to rise.
May 6, 2024
0
0
A Cleveland Clinic-led team of scientists and physicians have discovered that the immune checkpoint protein VISTA can directly turn off tumor-fighting T-cells during immunotherapy and resist treatment.
4 hours ago
0
2
